[go: up one dir, main page]

WO1998020856A3 - Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung - Google Patents

Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung Download PDF

Info

Publication number
WO1998020856A3
WO1998020856A3 PCT/EP1997/006257 EP9706257W WO9820856A3 WO 1998020856 A3 WO1998020856 A3 WO 1998020856A3 EP 9706257 W EP9706257 W EP 9706257W WO 9820856 A3 WO9820856 A3 WO 9820856A3
Authority
WO
WIPO (PCT)
Prior art keywords
active substances
well
ultrasound
production
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/006257
Other languages
English (en)
French (fr)
Other versions
WO1998020856A2 (de
Inventor
Werner Weitschies
Martina Bergmann
Volkmar Uhlendorf
Dieter Heldmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to EP97950159A priority Critical patent/EP0955998A2/de
Priority to AU53209/98A priority patent/AU5320998A/en
Priority to JP52216498A priority patent/JP2001506590A/ja
Publication of WO1998020856A2 publication Critical patent/WO1998020856A2/de
Publication of WO1998020856A3 publication Critical patent/WO1998020856A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Die Erfindung betrifft wirkstoffhaltige Mikropartikel, deren Wirkstoff in einer niedrig siedenen flüssigen Phase gelöst, suspendiert oder emulgiert ist, diese Partikel enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten in vivo Wirkstofffreisetzung, sowie Verfahren zur Herstellung der Partikel und Mittel.
PCT/EP1997/006257 1996-11-14 1997-11-04 Wirkstoffhaltige mikropartikel, diese enthaltende mittel, deren verwendung zur ultraschallgesteuerten freisetzung von wirkstoffen sowie verfahren zu deren herstellung Ceased WO1998020856A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97950159A EP0955998A2 (de) 1996-11-14 1997-11-04 Wirkstoffhaltige mikropartikel, diese enthaltende mittel, deren verwendung zur ultraschallgesteuerten freisetzung von wirkstoffen sowie verfahren zu deren herstellung
AU53209/98A AU5320998A (en) 1996-11-14 1997-11-04 Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
JP52216498A JP2001506590A (ja) 1996-11-14 1997-11-04 有効成分を含むミクロ粒子、該粒子を含む薬剤、有効成分の超音波制御放出のためのその使用ならびにその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996148664 DE19648664A1 (de) 1996-11-14 1996-11-14 Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
DE19648664.5 1996-11-14

Publications (2)

Publication Number Publication Date
WO1998020856A2 WO1998020856A2 (de) 1998-05-22
WO1998020856A3 true WO1998020856A3 (de) 1998-08-06

Family

ID=7812647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/006257 Ceased WO1998020856A2 (de) 1996-11-14 1997-11-04 Wirkstoffhaltige mikropartikel, diese enthaltende mittel, deren verwendung zur ultraschallgesteuerten freisetzung von wirkstoffen sowie verfahren zu deren herstellung

Country Status (5)

Country Link
EP (1) EP0955998A2 (de)
JP (1) JP2001506590A (de)
AU (1) AU5320998A (de)
DE (1) DE19648664A1 (de)
WO (1) WO1998020856A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264917B1 (en) 1996-10-28 2001-07-24 Nycomed Imaging As Targeted ultrasound contrast agents
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US6261537B1 (en) 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
JP4678591B2 (ja) * 2005-08-31 2011-04-27 カシオ電子工業株式会社 超音波破壊用マイクロカプセル
EP1978945A1 (de) * 2006-01-24 2008-10-15 Koninklijke Philips Electronics N.V. Verfahren zur herstellung eines partikels mit einem gaskern und einer schale sowie auf diese weise hergestellte partikel
WO2011046443A1 (en) * 2009-10-15 2011-04-21 Vivid As Ultrasound triggered controlled release drug delivery
US20140127309A1 (en) * 2011-06-03 2014-05-08 Rohm And Haas Company Encapsulated polar materials and methods of preparation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028874A1 (en) * 1993-06-11 1994-12-22 Unger Evan C Novel therapeutic delivery systems
WO1994028780A2 (en) * 1993-06-11 1994-12-22 Unger Evan C Methods of preparing gas and gaseous precursor-filled microspheres
WO1995007072A2 (de) * 1993-09-09 1995-03-16 Schering Aktiengesellschaft Wirkstoffe und gas enthaltende mikropartikel
WO1995015118A1 (en) * 1993-11-30 1995-06-08 Imarx Pharmaceutical Corp. Gas microspheres for topical and subcutaneous application
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028874A1 (en) * 1993-06-11 1994-12-22 Unger Evan C Novel therapeutic delivery systems
WO1994028780A2 (en) * 1993-06-11 1994-12-22 Unger Evan C Methods of preparing gas and gaseous precursor-filled microspheres
WO1995007072A2 (de) * 1993-09-09 1995-03-16 Schering Aktiengesellschaft Wirkstoffe und gas enthaltende mikropartikel
WO1995015118A1 (en) * 1993-11-30 1995-06-08 Imarx Pharmaceutical Corp. Gas microspheres for topical and subcutaneous application
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BECK P: "INFLUENCE OF POLYBUTYLCYANOACRYLATE NANOPARTICLES AND LIPOSOMES ON THE EFFICACY AND TOXICITY OF THE ANTICANCER DRUG MITOXANTRONE IN MURINE TUMOUR MODELS", JOURNAL OF MICROENCAPSULATION, vol. 10, no. 1, 1 January 1993 (1993-01-01), pages 101 - 114, XP000334997 *
GASPAR, ROGERIO: "Vectorização de medicamentos com nano-partículas de poli-alquilcianoacrilato (PACA)", REV. PORT. FARM., VOL. 41, NO. 3, PAGE(S) 36-8, 40-2, 44-5, 1991, XP002065277 *
HARRIS G R: "Are current hydrophone low frequency response standards acceptable for measuring mechanical/cavitation indices?", ULTRASONICS, vol. 6, no. 34, August 1996 (1996-08-01), pages 649-654, XP004035705 *
PORTER T R ET AL: "INTERACTION OF DIAGNOSTIC ULTRASOUND WITH SYNTHETIC OLIGONUCLEOTIDE-LABELED PERFLUOROCARBON-EXPOSED SONICATED DEXTROSE ALBUMIN MICROBUBBLES", JOURNAL OF ULTRASOUND IN MEDICINE, vol. 15, no. 8, August 1996 (1996-08-01), pages 577 - 584, XP002054859 *

Also Published As

Publication number Publication date
AU5320998A (en) 1998-06-03
WO1998020856A2 (de) 1998-05-22
EP0955998A2 (de) 1999-11-17
DE19648664A1 (de) 1998-05-28
JP2001506590A (ja) 2001-05-22

Similar Documents

Publication Publication Date Title
CA2329167A1 (en) Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
FR2779962B1 (fr) Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
GR3035219T3 (en) New active principle-containing microparticles, agents containing the same, their use for the ultrasonically controlled release of active principles, and process for preparing the same
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
DE3767029D1 (de) 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe.
ZA977482B (en) 7α(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents.
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
WO2001027119A3 (de) Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine
MXPA03005155A (es) 1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos.
CA2199993A1 (en) Methods of delivering materials into the skin, and compositions used therein
MXPA03006557A (es) METODO Y APARATO PARA REMOVER SUSTANCIAS DE LOS VASOS DEL CORAZON Y OTRAS PARTES DEL CUERPO, PARA MINIMIZAR O EVITAR DAnOS O DISFUNCIONES RENALES U OTROS.
DE69800307D1 (de) Fächer- oder scheiben-förmige Titanoxydteilchen, Verfahren zu ihrer Herstellung und ihre Verwendungen
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
SI0771788T1 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
ES2052671T3 (es) Agente en forma de particulas, adecuado para la separacion selectiva de cationes metalicos a partir de soluciones acuosas, procedimiento para su preparacion y su empleo.
WO1998020856A3 (de) Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
IT1276155B1 (it) Catalizzatori per l'ossiclorurazione dell'etilene,procedimento per la loro preparazione e procedimento di ossiclorurazione impiegante gli
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
WO1997007209A3 (en) Receptor
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
EP0618233A3 (de) Verfahren zur Herstellung und Aufarbeitung von in wässrigem Medium löslichen N-Hydroxyalkylchitosanen.
IL114712A0 (en) Microparticle preparations for eliminating dissolved substances from the blood
ATE289595T1 (de) Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten
HRP960063B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
WO1998020904A3 (de) Flüssigkeitsgefüllte mikropartikel mit neuem wirkungsprinzip und deren verwendung als diagnostika und therapeutika

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997950159

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 522164

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09308136

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997950159

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997950159

Country of ref document: EP